First comprehensive characterization of lip lymphoma: a population-based study [0.03%]
唇部淋巴瘤的首次全面特征描述：基于人口的调查研究结果
Pierre Loap,Youlia Kirova
Pierre Loap
Background: Lip lymphoma is an exceptionally rare extranodal lymphoma with limited data to guide clinical management. We conducted the first large-scale population-based analysis to characterize its epidemiology, treatmen...
Prognostic Role of Circular RNAs in Mantle Cell Lymphoma: A Competing Endogenous RNA Network Analysis [0.03%]
circRNA的预后作用及ceRNA网络在套细胞淋巴瘤中的作用分析
Chen-Xuan Huang,Xu-Dong Ma,Zhi-Yong Huang et al.
Chen-Xuan Huang et al.
Objective: This study evaluated the prognostic role of circular RNAs (circRNAs) in individuals diagnosed with mantle cell lymphoma (MCL), using the framework of the competing endogenous RNA (ceRNA) network model. ...
José Manuel Moreno-Mirón,Guillermo José Ruiz-Argüelles,Moisés Manuel Gallardo-Pérez et al.
José Manuel Moreno-Mirón et al.
The gastro-intestinal (GI; gut) microbiota is important in the development and function of haematopoiesis. Abnormalities of the gut microbiota are termed dysbiosis which is associated with the development and prognosis of haematological dis...
IPSS, IPSS-R and IPSS-M had no identical prognostic power depending on treatment in myelodysplastic syndromes [0.03%]
IPSS、IPSS-R和IPSS-M的预后价值在不同治疗方式下有所不同
Ghada Abichou,Michael Loschi,Rinzine Sammut et al.
Ghada Abichou et al.
Introduction The Revised International Prognostic Scoring System (IPSS-R) has long been the standard prognostic tool in the management of myelodysplastic syndromes (MDS). Recently, a new clinical-molecular prognostic model, the IPSS-M, was ...
Chronic Graft-Versus-Host Disease: A Review of Current Treatments Beyond Second-Line and Emerging Therapies [0.03%]
慢性移植物抗宿主病：第二线以外的当前治疗和新兴疗法综述
Aseel Saadeh,Dayana Jibrin,Michael Haddadin
Aseel Saadeh
Background: Chronic graft-versus-host disease (cGVHD) remains a major cause of late morbidity and non-relapse mortality following allogeneic hematopoietic cell transplantation. Early identification and intervention are cr...
FLUOROQUINOLONE PROPHYLAXIS FOR FEBRILE NEUTROPENIA IN AUTOLOGOUS HEMATOPOIETIC CELL TRANSPLANTATION: OUTCOMES AND RISK FACTORS [0.03%]
自身造血细胞移植中发热性中性粒细胞减少的氟喹诺酮类药物预防：结局和风险因素分析
Fernanda Batista Rosa Pinto,Fernanda Aline Moreira de Oliveira Meucci,Anita Cassoli Cortez et al.
Fernanda Batista Rosa Pinto et al.
Febrile neutropenia (FN) is a complication after autologous hematopoietic cell transplantation (auto-HCT). Although fluoroquinolone (FQ) prophylaxis can reduce FN rates, its use remains debated due to concerns about antimicrobial resistance...
Improving cure rates of B-cell acute lymphoblastic leukemia with chimeric antigen receptor T-cells [0.03%]
用嵌合抗原受体T细胞治疗B细胞急性淋巴细胞白血病以提高治愈率
Yannis K Valtis,Jae H Park
Yannis K Valtis
Chimeric antigen receptor T cell (CAR T) therapy was first approved for the treatment of children and young adults with relapsed/refractory (R/R) acute lymphoblastic leukemia (ALL). Since then, two additional CAR T products have been approv...
Post-transplant lymphoproliferative disorder (PTLD) following heart transplantation presenting as a retroperitoneal plasmacytoma - a case report and review of the literature [0.03%]
心脏移植后以腹膜后浆细胞瘤形式出现的移植后淋巴增生性疾病（PTLD）一例及文献复习
Yair Vilian,Adi Sherban,Elad Goldberg et al.
Yair Vilian et al.
Plasma cell neoplasms (PCNs) are a rare type of post-transplant lymphoproliferative disease (PTLD). Extramedullary plasmacytoma is a rare type of PCN, and is infrequently located in the retroperitoneum. According to the current literature, ...
Case Reports
Acta haematologica. 2025 Dec 24:1-21. DOI:10.1159/000550220 2025
A case series of SGLT2i improving hemoglobin in adults with myelodysplastic syndrome [0.03%]
SGLT2抑制剂改善骨髓增生异常综合征成人患者血红蛋白的病例系列分析
Patricia Olar,Stephanie Lee,Michael Fralick
Patricia Olar
Introduction: The objective of our case series was to assess the change in hemoglobin for adults with myelodysplastic syndrome (MDS) started on a sodium glucose cotransporter 2 inhibitor (SGLT2i) for their diabetes, heart...
Case Reports
Acta haematologica. 2025 Dec 24:1-10. DOI:10.1159/000550197 2025